Marie‐Claude Beauchamp

Author

McGill University ORCID

Also Known As

Beauchamp, Marie-Claude, M Beauchamp, Marie-Claude Beauchamp, Marie‐Claude Beauchamp, Meera Beauchamp

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

McGill University Jewish General Hospital McGill University Health Centre Université de Montréal Centre Hospitalier de l’Université de Montréal

About

Marie‐Claude Beauchamp is an author at McGill University specializing in medicine, cell biology, and ovarian cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	1.1K
2	Natural Sciences	2	2	126
3	Health Sciences	1	1	36
4	Public Health	1	1	41
5	Allergy	1	1	156

Marie‐Claude Beauchamp

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer Walter H. Gotlieb, Julio Saumet, Marie‐Claude Beauchamp, Gynecologic Oncology Epithelial Ovarian CancerMedicineGynecologyCancer BiologyOncology	2008	266
Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein. Christine Zouki, Marie‐Claude Beauchamp, Chantal Baron, Journal of Clinical Investigation Endothelial CellsImmunologyInnate ImmunityInflammationInflammatory Marker	1997	156
The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy Omar Serri, Ling Li, Jean‐Claude Mamputu, Clinical Endocrinology	2006	135
Induction of apoptosis by metformin in epithelial ovarian cancer: Involvement of the Bcl-2 family proteins Amber Yasmeen, Marie‐Claude Beauchamp, Ettie Piura, Gynecologic Oncology Epithelial Ovarian CancerMedicineApoptosisCell DeathPathology	2011	127
Anti-diabetic doses of metformin decrease proliferation markers in tumors of patients with endometrial cancer Ido Laskov, Laura M. Drudi, Marie‐Claude Beauchamp, Gynecologic Oncology Endocrine OncologyAnti-diabetic DosesMedicineGynecologyEndometrial Cancer	2014	103
Inhibition of PI3K-AKT-mTOR pathway sensitizes endometrial cancer cell lines to PARP inhibitors Charles‐André Philip, Ido Laskov, Marie‐Claude Beauchamp, BMC Cancer	2017	102
Control of anterior <scp>GR</scp> adient 2 ( <scp>AGR</scp> 2) dimerization links endoplasmic reticulum proteostasis to inflammation Marion Maurel, Joanna Obacz, Tony Avril, EMBO Molecular Medicine	2019	100
Relevance of the OCT1 transporter to the antineoplastic effect of biguanides Eric Segal, Amber Yasmeen, Marie‐Claude Beauchamp, Biochemical and Biophysical Research Communications Medicinal ChemistryBiochemistryAntineoplastic EffectNatural SciencesMedicine	2011	91
Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial Ovarian Cancer Marie‐Claude Beauchamp, Amber Yasmeen, Ariane Knafo, Journal of Oncology Insulin/insulin Growth FactorOncologyGrowth HormoneEndocrine-related CancerEpithelial Ovarian Cancer	2010	72
Peroxisome proliferator-activated receptor α and γ agonists upregulate human macrophage lipoprotein lipase expression Ling Li, Marie‐Claude Beauchamp, Geneviève Renier Atherosclerosis InflammationMolecular PharmacologyMetabolic SyndromeMolecular PhysiologyMedicine	2002	49

Page 1